Guidelines/Recommendations from Other Medical Societies
- American Association for Bronchology and Interventional Pulmonology
- American College of Surgeons
- American Thoracic Society
- American Society of Clinical Oncology
- American Society for Radiation Oncology
- European Respiratory Society
- European Society for Radiation Oncology
- European Society of Medical Oncology
- National Comprehensive Cancer Network
- The Royal College of Radiologists
- Society of Interventional Radiology
Information from Government/Non-Government Organizations
- World Health Organization Coronavirus disease (COVID-19) Pandemic
- European Medicines Agency
- Australia: Government Department of Health
- England: National Health Service
- Scotland: National Health Service
- U.S. National Institutes of Health
- U.S. Food and Drug Administration
- U.S. Centers for Disease Control and Prevention
Registries
TERAVOLT: Thoracic cancERs international coVid 19 cOLlaboraTion registry for thoracic cancers
The global TERAVOLT registry, initiated in March 2020, aims to provide outcome data specific to patients with thoracic cancer who contracted coronavirus. The data collected will hopefully guide disease management and define factors influencing associated morbidity and mortality.
Other cancer registries:
General COVID-19 Q&A: Facts and Experiences
- Find COVID-19 data by region, population, and/or demographic
- Johns Hopkins Global Coronavirus Tracker
- COVID-19 Poses Special Challenges to Cancer Care
- NEJM: Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
- The Treatment of Patients With Cancer and Containment of COVID-19: Experiences From Italy